The uremic solute indoxyl sulfate acts as an antioxidant against superoxide anion radicals under normal-physiological conditions

FEBS Letters

Volumn 584, Issue 13, 2010, Pages 2816-2820

  Miyamoto, Yohei ^a   Iwao, Yasunori ^b   Tasaki, Yuka ^a   Sato, Keizo ^c   Ishima, Yu ^a   Watanabe, Hiroshi ^a   Kadowaki, Daisuke ^a   Maruyama, Toru ^a   Otagiri, Masaki ^a,d  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d SOJO UNIVERSITY   (Japan)

Author keywords

Chemiluminescence; Electron paramagnetic resonance; Indoxyl sulfate; Neutrophil; Scavenging activity; Superoxide anion radical

Indexed keywords

HYDROXYL RADICAL; INDICAN; OXYGEN; SUPEROXIDE; XANTHINE; XANTHINE OXIDASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LEUKOCYTE ACTIVATION; OXIDATIVE STRESS; PRIORITY JOURNAL; UREMIA;

ANTIOXIDANTS; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; INDICAN; NEUTROPHILS; PYRROLES; SUPEROXIDES;

EID: 77953702891     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.04.046     Document Type: Article

References (25)

1. Ringoir S., Vanholder R., Massry S. Uremic Toxins 1987, Plenum Press, New York.
2. Niwa T. Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. Semin. Nephrol. 1996, 16:167-182.
3. Motojima M., Nishijima F., Ikoma M., Kawamura T., Yoshioka T., Fogo A.B., Sakai T., Ichikawa I. Role for " uremic toxin" in the progressive loss of intact nephrons in chronic renal failure. Kidney Int. 1991, 40:461-469.
4. Miyazaki T., Ise M., Seo H., Niwa T. Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys. Kidney Int. Suppl. 1997, 62:S15-S22.
5. Gelasco A.K., Raymond J.R. Indoxyl sulfate induces complex redox alterations in mesangial cells. Am. J. Physiol. Renal Physiol. 2006, 290:F1551-F1558.
6. Motojima M., Hosokawa A., Yamato H., Muraki T., Yoshioka T. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells. Kidney Int. 2003, 63:1671-1680.
7. Dou L., Jourde-Chiche N., Faure V., Cerini C., Berland Y., Dignat-George F., Brunet P. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J. Thromb. Haemost. 2003, 5:1302-1308.
8. Shimoishi K., Anraku M., Kitamura K., Tasaki Y., Taguchi K., Hashimoto M., Fukunaga E., Maruyama T., Otagiri M. An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure. Pharmaceut. Res. 2007, 24:1283-1289.
9. Ohta Y., Sahashi D. l-Tryptophan administration promotes the reversion of pre-established chronic liver injury in rats treated with carbon tetrachloride. J. Nutr. Biochem. 2002, 13:550.
10. Cano A., Alcaraz O., Arnao MB. Free radical-scavenging activity of indolic compounds in aqueous and ethanolic media. Anal. Bioanal. Chem. 2003, 376:33-37.
11. Matuszak Z., Reszka K., Chignell C.F. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radical Biol. Med. 1997, 23:367-372.
12. Yoshida M., Fukuda A., Hara M., Terada A., Kitanaka Y., Owada S. Melatonin prevents the increase in hydroxyl radical-spin trap adduct formation caused by the addition of cisplatin in vitro. Life Sci. 2003, 72:1773-1780.
13. Fukutomi J., Fukuda A., Fukuda S., Hara M., Terada A., Yoshida M. Scavenging activity of indole compounds against cisplatin-induced reactive oxygen species. Life Sci. 2006, 80:254-257.
14. Cano A., Alcaraz O., Arnao M.B. Free radical-scavenging activity of indolic compounds in aqueous and ethanolic media. Anal. Bioanal. Chem. 2003, 376:33-37.
15. Chyan Y.J., Poeggeler B., Omar R.A., Chain D.G., Frangione B., Ghiso J., Pappolla M.A. Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J. Biol. Chem. 1999, 274:21937-21942.
16. Vanholder R., De Smet R., Glorieux G., Argilés A., Baurmeister U., Brunet P., Clark W., Cohen G., De Deyn PP., Deppisch R., Descamps-Latscha B., Henle T., Jörres A., Lemke HD., Massy ZA., Passlick-Deetjen J., Rodriguez M., Stegmayr B., Stenvinkel P., Tetta C., Wanner C., Zidek W. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003, 63:1934-1943. European Uremic Toxin Work Group (EUTox).
17. Haining J.L., Legan J.S. Fluorometric assay for xanthine oxidase. Anal. Biochem. 1967, 21:337-343.
18. Zhang H., Joseph J., Vasquez-Vivar J., Karoui H., Nsanzumuhire C., Martasek P., Tordo P., Kalyanaraman B. Detection of superoxide anion using an isotopically labeled nitrone spin trap: potential biological applications. FEBS Lett. 2000, 473:58-62.
19. Martinez A.W., Recht N.S., Hostetter T.H., Meyer T.W. Removal of P-cresol sulfate by hemodialysis. J. Am. Soc. Nephrol. 2005, 16:3430-3436.
20. Schepers E., Meert N., Glorieux G., Goeman J., Van der Eycken J., Vanholder R. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol. Dial. Transplant. 2007, 22:592-596.
21. Priyadarsini K.I., Khopde S.M., Kumar S.S., Mohan H. Free radical studies of ellagic acid, a natural phenolic antioxidant. J. Agric. Food Chem. 2002, 50:2200-2206.
22. Cuzzocrea S., Riley D.P., Caputi A.P., Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 2001, 53:135-159.
23. Harrison D., Griendling K.K., Landmesser U., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 2003, 91:7A-11A.
24. Lassegue B., Griendling K.K. Reactive oxygen species in hypertension; an update. Am. J. Hypertens. 2004, 17:852-860.
25. Becker B.F. Towards the physiological function of uric acid. Free Radical Biol. Med. 1993, 14:615-631.